Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 12975462)

1.

Cirrhotic cardiomyopathy: review of pathophysiology and treatment.

Chayanupatkul M, Liangpunsakul S.

Hepatol Int. 2014 Jul;8(3):308-315.

2.

Anchored protein kinase A signalling in cardiac cellular electrophysiology.

Soni S, Scholten A, Vos MA, van Veen TA.

J Cell Mol Med. 2014 Nov;18(11):2135-46. doi: 10.1111/jcmm.12365. Epub 2014 Sep 12.

3.

Polyunsaturated Fatty acids modify the gating of kv channels.

Moreno C, Macias A, Prieto A, De La Cruz A, Valenzuela C.

Front Pharmacol. 2012 Sep 10;3:163. doi: 10.3389/fphar.2012.00163. eCollection 2012.

4.

HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.

Link MS, Exner DV, Anderson M, Ackerman M, Al-Ahmad A, Knight BP, Markowitz SM, Kaufman ES, Haines D, Asirvatham SJ, Callans DJ, Mounsey JP, Bogun F, Narayan SM, Krahn AD, Mittal S, Singh J, Fisher JD, Chugh SS.

Heart Rhythm. 2011 Aug;8(8):1340-56. doi: 10.1016/j.hrthm.2011.06.008. Epub 2011 Jun 14. No abstract available.

5.

Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction.

Enns LC, Bible KL, Emond MJ, Ladiges WC.

BMC Res Notes. 2010 Nov 16;3:307. doi: 10.1186/1756-0500-3-307.

6.

Protein kinase A is a target for aging and the aging heart.

Enns LC, Pettan-Brewer C, Ladiges W.

Aging (Albany NY). 2010 Apr;2(4):238-43.

7.

A-kinase anchoring proteins: getting to the heart of the matter.

Scott JD, Santana LF.

Circulation. 2010 Mar 16;121(10):1264-71. doi: 10.1161/CIRCULATIONAHA.109.896357. Review. No abstract available.

8.

Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease.

Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL; International Long QT Syndrome Investigative Group.

Ann Noninvasive Electrocardiol. 2008 Oct;13(4):327-31. doi: 10.1111/j.1542-474X.2008.00250.x.

9.

AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.

Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, Bristow MR, Kunkel MT, Newton AC, Langeberg LK, Scott JD.

Mol Cell. 2008 Oct 24;32(2):169-79. doi: 10.1016/j.molcel.2008.08.030.

10.

Role of the S6 C-terminus in KCNQ1 channel gating.

Boulet IR, Labro AJ, Raes AL, Snyders DJ.

J Physiol. 2007 Dec 1;585(Pt 2):325-37. Epub 2007 Oct 11.

11.

A novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome.

Aizawa Y, Ueda K, Scornik F, Cordeiro JM, Wu Y, Desai M, Guerchicoff A, Nagata Y, Iesaka Y, Kimura A, Hiraoka M, Antzelevitch C.

J Cardiovasc Electrophysiol. 2007 Sep;18(9):972-7. Epub 2007 Jul 26.

12.

QTc and psychopharmacs: are there any differences between monotherapy and polytherapy.

Sumić JC, Barić V, Bilić P, Herceg M, Sisek-Sprem M, Jukić V.

Ann Gen Psychiatry. 2007 May 3;6:13.

13.

Computational biology in the study of cardiac ion channels and cell electrophysiology.

Rudy Y, Silva JR.

Q Rev Biophys. 2006 Feb;39(1):57-116. Epub 2006 Jul 19. Review.

14.

Long QT syndrome: from channels to cardiac arrhythmias.

Moss AJ, Kass RS.

J Clin Invest. 2005 Aug;115(8):2018-24.

15.

Return of calcium: manipulating intracellular calcium to prevent cardiac pathologies.

Wang Y, Goldhaber JI.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5697-8. Epub 2004 Apr 12. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk